Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Japanese Stocks Can Extend Leadership

BY | ETF Database
09/23/2025 | 748 VIEWS
  • Related Symbols
  • DXJ
Entering Wednesday, Japanese stocks sported a wide year-to-date advantage over their U.S. counterparts. This high highlighting the fact that in 2025, there are other games in town besides domestic stocks.What has gone overlooked by some market participants is that with the right Japan ETFs, they could have generated better performance than the S&P 500 for several years now. For example, the WisdomTree Japan Hedged Equity Fund (DXJ B-) returned 116.3% for the three years ending Sept. 16 compared to 69.4% for the S&P 500. Year-to-date, that advantage is 500 basis points in favor of the Japan ETF. On the surface, those data points might imply that Japanese stocks are tired and may be due for a pullback or period of sideways trading. Upon further examination, there are fundamental tailwinds underpinning strength in Japanese equities, indicating DXJ could have more upside ahead.Economic Strength Supports DXJ CaseJapan’s increasingly vibrant macroeconomic picture could augur well for DXJ heading into the fourth quarter and next year. “The economy is continuing to show signs of recovery, especially in domestic demand,” notes Naoki Kamiyama, chief investment officer at Amova Asset Management. “April–June 2025 corporate earnings were solid and GDP growth for the quarter exceeded an annualised 1%, showing that the impact of US tariffs has so far been limited. Perhaps the most important driver of the recent rally is expectations that domestic consumption will remain robust for the foreseeable future.” The point about rising domestic consumption in Japan is highly relevant to investors mulling DXJ. The ETF allocates 19.42% to consumer discretionary stocks making that its second-largest sector exposure. DXJ may offer a surprise, too: positive leverage to the long-awaited Federal Reserve rate cut that arrived on Wednesday. Currency-hedged ETFs such as DXJ typically benefit from dollar strength. However, a stronger yen doesn’t have to be a drag for Japanese companies, including DXJ member firms. Amova’s Kamiyama sees Japanese corporations as adapting with aplomb to U.S. monetary and trade policy. “The main focus appears to be shifting from currency effects to corporate Japan maintaining US-bound export volumes,” added the chief investment officer. “With the Fed seemingly poised to ease, Japanese export volumes could be maintained as lower interest rates may support US consumer confidence. Regarding US tariffs, Japanese companies are adapting; for example, some firms are opting to move production to the US.” As for the Bank of Japan, Kamiyama said it’s unlikely to boost rates prior to its December meeting. For now, yields on Japanese government bonds likely aren’t high enough to stoke rampant buying. This indicates stocks are the preferred asset with which to access Japan. For more news, information, and analysis, visit the Modern Alpha Content Hub.

More Commentary

Top Performing Leveraged/Inverse ETFs: 09/28/2025
BY | ETF Database
10/01/2025 | 258 VIEWS
Buy on the Dip Prospects: October 1 Edition
BY | ETF Database
10/01/2025 | 281 VIEWS
Sell on the Pop Prospects: September 24 Edition
BY | ETF Database
09/26/2025 | 443 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.